CRINETICS PHARMACEUTICALS INC <CRNX.O>: UBS CUTS TO NEUTRAL FROM BUY; CUTS TARGET PRICE TO $85 FROM $55

Reuters2026/07/28 14:11

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

CRINETICS PHARMACEUTICALS INC

: UBS CUTS TO NEUTRAL FROM BUY; CUTS TARGET PRICE TO $85 FROM $55

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

CRINETICS PHARMACEUTICALS INC <CRNX.O>: UBS CUTS TO NEUTRAL FROM BUY; CUTS TARGET PRICE TO $85 FROM $55

You may also like

Crypto prices